Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,163,680 papers from all fields of science
Search
Sign In
Create Free Account
Olopatadine hydrochloride
Known as:
Dibenz[B,E]Oxepin-2-Acetic Acid, 11-[3-(Dimethylamino)Propylidene]-6,11-Dihydro-, Hydrochloride, (Z)-
, Hydrochloride, Olopatadine
, Olopatadine Hydrochloride [Chemical/Ingredient]
The hydrochloride salt form of olopatadine, a dual action selective histamine H1 receptor antagonist and mast cell stabilizer with anti-allergic…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
Allergic Conjunctivitis
Drug Allergy
Histamine H1 Receptor Antagonists [MoA]
In Blood
Expand
Broader (4)
Anti-Allergic Agents
Anti-Inflammatory Agents, Non-Steroidal
Histamine H1 Antagonists, Non-Sedating
olopatadine
Narrower (4)
KW 4679
PATANASE
Patanol
Pazeo
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice
T. Amano
,
T. Takeda
,
H. Yano
,
T. Tamura
British Journal of Dermatology
2007
Corpus ID: 10395858
Background The skin barrier function in patients with atopic dermatitis is disrupted and prolonged topical steroid therapy…
Expand
2006
2006
Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: a post hoc analysis of data from a conjunctival allergen challenge study.
I. Finegold
,
D. Granet
,
P. D'Arienzo
,
A. Epstein
Clinical Therapeutics
2006
Corpus ID: 736253
2006
2006
Neuronal conditions of spinal cord in dermatitis are improved by olopatadine.
Rie Hamada
,
M. Seike
,
R. Kamijima
,
Mitsunori Ikeda
,
H. Kodama
,
H. Ohtsu
European Journal of Pharmacology
2006
Corpus ID: 24959077
2005
2005
Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity
T. Tamura
,
M. Matsubara
,
K. Hasegawa
,
K. Ohmori
,
A. Karasawa
Clinical and Experimental Allergy
2005
Corpus ID: 38106011
Background Olopatadine hydrochloride (olopatadine; Allelock®) is one of the second‐generation antihistamines that are treated for…
Expand
2005
2005
The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
T. Tamura
,
T. Amano
,
K. Ohmori
,
H. Manabe
European Journal of Pharmacology
2005
Corpus ID: 39554999
2005
2005
Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis*
M. Abelson
,
P. Gomes
,
+4 authors
S. Robertson
Current Medical Research and Opinion
2005
Corpus ID: 37014563
ABSTRACT Background: A new formulation of olopatadine hydrochloride ophthalmic solution (olopatadine 0.2%) was evaluated in two…
Expand
2003
2003
Effects of orally administered olopatadine hydrochloride on the ocular allergic reaction in rats
T. Tamura
,
Hitoshi Sato
,
I. Miki
,
Kazuo T. Suzuki
,
K. Ohmori
,
A. Karasawa
2003
Corpus ID: 73344317
ABSTRACT Background Olopatadine hydrochloride is an antiallergic agent with histamine H 1 receptor antagonistic action. We…
Expand
2002
2002
Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells.
D. Kempuraj
,
Man Huang
,
+7 authors
T. Theoharides
Annals of Allergy, Asthma & Immunology
2002
Corpus ID: 34427518
2002
2002
Rapid Effects of Olopatadine Hydrochloride on the Histamine‐Induced Skin Responses
K. Morita
,
T. Koga
,
Y. Moroi
,
K. Urabe
,
M. Furue
Journal of dermatology (Print)
2002
Corpus ID: 28290169
Olopatadine hydrochloride is one of the second‐generation nonsedating antihistamines that are used for treating allergic…
Expand
2000
2000
Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis
M. Alexander
,
S. Allegro
,
A. Hicks
Advances in Therapy
2000
Corpus ID: 10346399
In this 2-week, randomized, crossover study, ophthalmic solutions of nedocromil sodium 2% and olopatadine hydrochloride 0.1% were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE